Library design for NMR-based screening

Drug Discovery Today

Volumn 6, Issue 3, 2001, Pages 133-140

  Lepre, Christopher A ^a  

^a VERTEX PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMBINATORIAL CHEMISTRY; DRUG DESIGN; DRUG MIXTURE; DRUG SCREENING; DRUG SOLUBILITY; DRUG SYNTHESIS; LIBRARY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REVIEW; SCREENING;

EID: 0035252844     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(00)01616-0     Document Type: Review

References (72)

1. Screening mixtures for biological activity by NMR
2. NOE pumping: a novel NMR technique for identification of compounds with binding affinity to macromolecules
3. NOE pumping. 2. A high-throughput method to determine compounds with binding affinity to macromolecules by NMR
4. The SHAPES strategy: an NMR-based approach for lead generation in drug discovery
5. Discovering high-affinity ligands for proteins: SAR by NMR
6. Mixture analysis in combinatorial chemistry. Application of diffusion-resolved NMR spectroscopy
7. Diffusion-edited NMR - affinity NMR for direct observation of molecular interactions
8. Screening mixtures by affinity NMR
9. One-dimensional relaxation- and diffusion-edited NMR methods for screening compounds that bind to macromolecules
10. Characterization of ligand binding by saturation transfer difference NMR spectroscopy, Angew. Chem
11. Detecting binding affinity to immobilized receptor proteins in compound libraries by HR-MAS-STD NMR
12. Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water
13. Approaches to the design of combinatorial libraries
14. The in silico world of virtual libraries
15. Approaches to virtual library design
16. Experimental designs for selecting molecules from large chemical databases
17. New methodology for profiling combinatorial libraries and screening sets: cleaning up the design process with HARPick
18. Virtual compound libraries: a new approach to decision making in molecular discovery research
19. Neighborhood behavior: A useful concept for validation of 'molecular diversity' descriptors
20. Molecular diversity and representivity in chemical databases
21. Molecular diversity and its analysis
22. Diversity assessment
23. Hierarchical grouping to optimize and objective function
24. Clustering using a similarity measure based on shared near neighbors
25. Beyond mere diversity: tailoring combinatorial libraries for drug discovery
26. Chemoinformatics - a new name for an old problem?
27. Chemoinformatics - predicting the physicochemical properties of 'drug-like' molecules
28. Computational methods for the prediction of 'drug-likeness'
29. Virtual screening of intestinal drug permeability
30. Molecular diversity in chemical databases: comparison of medicinal chemistry knowledge bases and databases of commercially available compounds
31. Indentification of biological activity profiles using substructure analysis and genetic algorithms
32. Toward designing drug-like libraries: a novel computational approach for prediction of drug feasibility of compounds
33. Can we learn to distinguish between 'drug-like' and 'nondrug-like' molecules?
34. Designing libraries with CNS activity
35. A scoring scheme for discriminating between drugs and nondrugs
36. Optimization of chemical libraries by neural networks
37. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
38. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases
39. Property distribution of drug-related chemical databases
40. Drug-like index: a new approach to measure drug-like compounds and their diversity
41. Strategic pooling of compounds for high-throughput screening
42. The properties of known drugs. 1. Molecular frameworks
43. Properties of known drugs. 2. Side chains
44. Reactive compounds and in vitro false positives in HTS
45. Similarity measures for rational set selection and analysis of combinatorial libraries: the diverse property-derived (DPD) approach
46. Virtual screening - an overview
47. The design of lead-like combinatorial libraries, Angew. Chem
48. The maximal affinity of ligands
49. Isotope-filtered affinity NMR
50. High-throughput nuclear magnetic resonance-based screening
51. Improved method for estimating water solubility from octanol-water partition coefficient
52. Atom/fragment contribution method for estimating octanol-water partition coefficients
53. Automation of NMR measurements and data evaluation for systematically screening interactions of small molecules with target proteins
54. Scaffold-hopping: by topological pharmacophore search: a contribution to virtual screening, Angew. Chem
55. Similarity and dissimilarity: a medicinal chemist's view
56. Chemical similarity searching
57. Application of nearest-neighbor and cluster analysis in pharmaceutical lead discovery
58. Enhancing the hit-to-lead properties of lead optimization libaries
59. Lead generation using pharmacophore mapping and three-dimensional database searching: application to muscarinic M3 receptor antagonists
60. Combinatorial target-guided ligand assembly: identification of potent subtype-selective c-Src inhibitors
61. Novel inhibitors of DNA gyrase: 3D structure based needle screening, hit validation by biophysical methods, and 3D guided optimization
62. RECAP - Retrosynthetic combinatorial analysis procedure: a powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry
63. Combinatorial docking and combinatorial chemistry: design of potent non-peptide thrombin inhibitors
64. Structure-based library design: molecular modelling merges with combinatorial chemistry
65. Successful virtual screening of a chemical database for farnesyltransferase inhibitor leads
66. Virtual combinatorial syntheses and computational screening of new potential anti-herpes compounds
67. Rational discovery of novel nuclear hormone receptor antagonists
68. Targeted molecular diversity in drug discovery: integration of structure-based design and combinatorial chemistry
69. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules
70. Rational screening set design and compound selection: cascaded clustering